These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 4340872)

  • 1. Catechol O-methyltransferase. IV. Factors affecting m- and p-methylation of substituted catechols.
    Creveling CR; Morris N; Shimizu H; Ong HH; Daly J
    Mol Pharmacol; 1972 Jul; 8(4):398-409. PubMed ID: 4340872
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemical structure-activity correlation in the O-methylation of substituted catechols by catechol O-methyltransferase.
    Katz R; Jacobson AE
    Mol Pharmacol; 1972 Sep; 8(5):594-9. PubMed ID: 5083617
    [No Abstract]   [Full Text] [Related]  

  • 3. Interactions between estrogens and catechol amines. 3. Studies on the methylation of catechol estrogens, catechol amines and other catechols by the ctechol-O-methyltransferases of human liver.
    Ball P; Knuppen R; Haupt M; Breuer H
    J Clin Endocrinol Metab; 1972 Apr; 34(4):736-46. PubMed ID: 5012775
    [No Abstract]   [Full Text] [Related]  

  • 4. A sensitive radioenzymatic assay for catechol drugs.
    Durrett LR; Ziegler MG
    J Neurosci Res; 1980; 5(6):587-98. PubMed ID: 7205995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catechol-O-methyltransferase. II. A new class of inhibitors of catechol-o-methyltransferase; 3,5-dihydroxy-4-methoxybenzoic acid and related compounds.
    Nikodejevic B; Senoh S; Daly JW; Creveling CR
    J Pharmacol Exp Ther; 1970 Jul; 174(1):83-93. PubMed ID: 5432229
    [No Abstract]   [Full Text] [Related]  

  • 6. Catechol metabolites of polychlorinated biphenyls inhibit the catechol-O-methyltransferase-mediated metabolism of catechol estrogens.
    Garner CE; Burka LT; Etheridge AE; Matthews HB
    Toxicol Appl Pharmacol; 2000 Jan; 162(2):115-23. PubMed ID: 10637135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of catechol-O-methyl transferase by L-dopa and decarboxylase inhibitors.
    Baldessarini RJ
    J Pharm Pharmacol; 1972 Jan; 24(1):78-80. PubMed ID: 4401326
    [No Abstract]   [Full Text] [Related]  

  • 8. A sensitive radioenzymatic assay for dopamine, norepinephrine, and epinephrine in plasma and tissue.
    Ben-Jonathan N; Porter JC
    Endocrinology; 1976 Jun; 98(6):1497-507. PubMed ID: 1278114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A differential pulse polarographic assay for O-methylation of catechols by catechol-O-methyltransferase.
    Sternson LA; Sternson AW; Bannister SJ
    Anal Biochem; 1976 Sep; 75(1):142-52. PubMed ID: 962125
    [No Abstract]   [Full Text] [Related]  

  • 10. Catechol O-methyltransferase. The para- and meta-O-methylations of noradrenaline.
    Frère JM; Verly WG
    Biochim Biophys Acta; 1971 Apr; 235(1):73-84. PubMed ID: 5519141
    [No Abstract]   [Full Text] [Related]  

  • 11. A simplified radiometric assay for plasma norepinephrine and epinephrine.
    Passon PG; Peuler JD
    Anal Biochem; 1973 Feb; 51(2):618-31. PubMed ID: 4349454
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of aromatic aldehydes on O-methylation of dopamine and norepinephrine in vitro.
    Ho BT; Gardner PM; Englert LF; Walker KE
    J Pharm Sci; 1974 Aug; 63(8):1261-4. PubMed ID: 4859299
    [No Abstract]   [Full Text] [Related]  

  • 13. Proceedings: Catechol-O-methyltransferase measurements using spectrophotometric and radiometric procedures.
    Bade P; Christ W; Rakow D
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R3. PubMed ID: 4276512
    [No Abstract]   [Full Text] [Related]  

  • 14. N-methylation of indolealkylamines in the brain with a new methyl donor.
    Leysen J; Laduron P
    Adv Biochem Psychopharmacol; 1974; 11(0):65-74. PubMed ID: 4845689
    [No Abstract]   [Full Text] [Related]  

  • 15. Different metabolism of norepinephrine and epinephrine by catechol-O-methyltransferase and monoamine oxidase in rats.
    Eisenhofer G; Finberg JP
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1242-51. PubMed ID: 8138937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of ortho- and meta-nitrated inhibitors of catechol-O-methyltransferase: interactions with the active site and regioselectivity of O-methylation.
    Palma PN; Rodrigues ML; Archer M; Bonifácio MJ; Loureiro AI; Learmonth DA; Carrondo MA; Soares-da-Silva P
    Mol Pharmacol; 2006 Jul; 70(1):143-53. PubMed ID: 16618795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between estrogens and neurotransmitters: biochemical mechanism.
    Breuer H; Köster G
    Adv Biosci; 1975; 15():287-300. PubMed ID: 240745
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification of major metabolites of the catechol-O-methyltransferase inhibitor nitecapone in the rat and dog.
    Wikberg T; Taskinen J
    Drug Metab Dispos; 1993; 21(2):325-33. PubMed ID: 8097704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantum chemical studies on drug actions. II. Quantum chemical data on derivatives of catechol, indole, imidazole amines and of spermine and spermidine.
    Kumbar M; Sankar DV
    Res Commun Chem Pathol Pharmacol; 1973 Jan; 5(1):45-72. PubMed ID: 4539867
    [No Abstract]   [Full Text] [Related]  

  • 20. Sources and significance of plasma levels of catechols and their metabolites in humans.
    Goldstein DS; Eisenhofer G; Kopin IJ
    J Pharmacol Exp Ther; 2003 Jun; 305(3):800-11. PubMed ID: 12649306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.